The RDGenePP (Rare Disease Gene Panel Program) is an innovative initiative supported by Sanofi. Its main goal is to tackle the pressing issue of diagnosing lysosomal storage diseases accurately and promptly. This program seeks to enhance patient care and outcomes for those suffering from rare genetic conditions.
MAT-GLB-2401585-6.0 - 12/2024
